Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage?

European Journal of Human Genetics

Volumn 17, Issue 3, 2009, Pages 284-286

  D'Adamo, Pio ^a   Guerci, Veronica Ileana ^b   Fabretto, Antonella ^b   Faletra, Flavio ^b   Grasso, Domenico Leonardo ^a   Ronfani, Luca ^a   Montico, Marcella ^a   Morgutti, Marcello ^a   Guastalla, PierPaolo ^a   Gasparini, Paolo ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26;

CELL DEATH; CELL DIFFERENTIATION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; DYSENTERY; EPIDERMIS; EXTRACELLULAR MATRIX; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC MARKER; GENETIC TRAIT; GENOME ANALYSIS; HETEROZYGOTE; HUMAN; KERATINIZATION; KERATINOCYTE; LETTER; MICROBIAL ACTIVITY; MUTATIONAL ANALYSIS; NATURAL SELECTION; NONHUMAN; PATHOGENESIS; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; SHIGELLOSIS; SKIN INFECTION; SKIN PROTECTION; SKINFOLD THICKNESS;

CONNEXINS; EPIDERMIS; GENE FREQUENCY; HEARING LOSS; HETEROZYGOTE; HUMANS;

EID: 60749114435     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.225     Document Type: Letter

References (14)

1. Roth Jr EF, Raventos-Suarez C, Rinaldi A, Nagel RL: Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc Natl Acad Sci USA 1983; 80: 298-299.
2. Gabriel SE, Brigman KN, Koller BH et al: Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 1994; 266: 107-109.
3. Zelante L, Gasparini P, Estivill X et al: Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997; 6: 1605-1609.
4. Lucotte G, Dieterlen F: The 35delG mutation in the connexin 26 gene (GJB2) associated with congenital deafness: European carrier frequencies and evidence for its origin in ancient Greece. Genet Test 2005; 9: 20-25.
5. Gasparini P, Rabionet R, Barbujani G et al: High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet 2000; 8: 19-23.
6. Brobby GW, Müller-Myhsok B, Horstmann RD: Connexin 26 R143W mutation associated with recessive nonsyndromic sensorineural deafness in Africa. N Engl J Med 1998; 338: 548-550.
7. Hamelmann C, Amedofu GK, Albrecht K et al: Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana. Hum Mutat 2001; 18: 84-85.
8. Meyer CG, Amedofu GK, Brandner JM et al: Selection for deafness? Nat Med 2002; 8: 1332-1333.
9. Man YK, Trolove C, Tattersall D et al: A deafness-associated mutant human connexin 26 improves the epithelial barrier in vitro. J Membr Biol 2007; 218: 29-37.
10. Common JE, Di W-L, Davies D et al: Further evidence for heterozygote advantage of GJB2 deafness mutations: A link with cell survival. J Med Genet 2004; 41: 573-575.
11. Lai-Cheong JE, Arita K, McGrath JA: Genetic diseases of junctions. J Invest Dermatol 2007; 127: 2713-2725.
12. Guastalla P, Guerci V, Faretto A et al: Epidermal sonography can detect epidermal thickening in GJB2 carriers. Radiology, (In press).
13. Tran Van Nhieu G, Clair C, Bruzzone R et al: Connexin-dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells. Nat Cell Biol 2003; 5: 720-726.
14. Pier GB, Grout M, Zaidi T et al: Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 1998; 393: 79-82.